Supriya Lifescience (SUPRIYA) | Stock Overview & Key Data
Supriya Lifescience Performance Comparison
Stock Range
Today's Range
Low: ₹700.00
High: ₹733.15
on September 26, 2025
52 Week Range
Low: ₹511.40
High: ₹842.00
on October 23, 2024
on April 3, 2025
All-Time High: ₹842.00 on March 31, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR56.6B
EPS
22.16
P/E Ratio (TTM)
31.98
Forward P/E
23.25
P/B Ratio
5.70
PEG Ratio
-1.45
Div. Yield
0.27%
ROE
18.86%
Beta
0.184
Debt to Equity
0.54
Financial Highlights
Profitability
Gross Margin
78.10%
Operating Margin
31.19%
Profit Margin
26.16%
Returns and Earnings
Return on Assets (TTM)
16.90%
Return on Equity (TTM)
18.86%
EBITDA
INR2.6B
Net Income (TTM)
INR1.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR84.61
Quarterly Revenue Growth (YoY)
-9.70%
Quarterly Earnings Growth (YoY)
-22.10%
Dividend Information
Last 12-Month Dividend
₹1.80
Current Dividend Yield
0.27%
3-Year Average Dividend Yield
0.17%
3-Year Average Annual Dividend
₹0.80
3-Year Total Dividends
₹2.40
Ex-Dividend Date
September 4, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Supriya Lifescience SUPRIYA | 56.60B Mid-cap | -3.33% | 6.68% | 3.14% | -5.54% | -7.20% | 24.45% | 133.96% | 45.13% |
| Biocon BIOCON | 455.97B Large-cap | -8.21% | -5.41% | -3.31% | -2.70% | -8.11% | -8.12% | 16.48% | -25.13% |
| OneSource Specialty ONESOURCE | 207.35B Large-cap | -2.78% | -3.87% | -10.63% | 4.11% | 4.67% | 4.67% | 4.67% | 4.67% |
| Concord Biotech CONCORDBIO | 163.87B Mid-cap | -7.65% | -8.25% | -12.97% | -5.35% | -27.15% | -23.56% | 66.04% | 66.04% |
| Blue Jet Healthcare BLUEJET | 112.12B Mid-cap | -4.94% | -8.69% | -25.73% | -24.41% | 11.85% | 25.39% | 65.68% | 65.68% |
| Dishman Carbogen DCAL | 44.90B Small-cap | -6.39% | 3.53% | 14.40% | 26.29% | -1.42% | 53.25% | 191.75% | 71.91% |
Ownership & Short Interest
Insider Ownership
72.31%
Institutional Ownership
4.95%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
411K
Average 90-Day Volume
236K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SUPRIYA's 52-week high and low?
- In the last 52 weeks, Supriya Lifescience reached a high of ₹842.00 (on April 3, 2025) and a low of ₹511.40 (on October 23, 2024).
- What is the market cap and P/E ratio for SUPRIYA?
- Curious about Supriya Lifescience's size and valuation? Its market capitalization stands at 56.60B. When it comes to valuation, the P/E ratio (trailing twelve months) is 31.98, and the forward P/E (looking ahead) is 23.25.
- Does SUPRIYA pay dividends? If so, what's the yield?
- Yes, Supriya Lifescience is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.27%, and the company has paid an average of ₹0.80 per share annually over the past 3 years.
- Who are Supriya Lifescience's main competitors or similar companies to consider before investing?
When looking at Supriya Lifescience, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON455.97B Healthcare Biotechnology -8.12% 16.48% OneSource Specialty
ONESOURCE207.35B Healthcare Biotechnology 4.67% 4.67% Concord Biotech
CONCORDBIO163.87B Healthcare Biotechnology -23.56% 66.04% Blue Jet Healthcare
BLUEJET112.12B Healthcare Biotechnology 25.39% 65.68% Dishman Carbogen
DCAL44.90B Healthcare Biotechnology 53.25% 191.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Supriya Lifescience Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Supriya Lifescience's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.86%, the Debt to Equity ratio from the most recent quarter is 0.54, and its Gross Profit Margin stands at 78.10%.
- What is the recent revenue and earnings growth for SUPRIYA?
- Looking at Supriya Lifescience's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by -9.70%, and quarterly earnings saw a YoY growth of -22.10%.
- How much of SUPRIYA stock is held by insiders and institutions?
- Wondering who owns Supriya Lifescience stock? Company insiders (like executives and directors) hold about 72.31% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.95%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.